We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300133:SZSEZhejiang Huace Film & TV Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥7.69

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at CNY 7.69, well above the DCF‑derived fair value of roughly CNY 4.9 and a P/E of 59× versus an industry average of 18×, indicating significant overvaluation. Technical signals are mixed: the 20‑day SMA (8.52) sits above the current price, the 50‑day SMA (8.76) is also higher, and the MACD histogram is negative, suggesting bearish momentum, while the RSI of 38 points to a mildly oversold condition. Recent news highlighted the global launch of the historical series “Swords Into Plowshares,” which could boost short‑term visibility but does not yet translate into revenue growth, as the company posted a 52.2% decline in top‑line sales. The balance sheet shows ample cash (CNY 3.9 bn) but also a sizable debt load (CNY 1.34 bn) and negative free cash flow, raising questions about the sustainability of its modest 0.16% dividend.
Given the high 30‑day volatility (~73%), low beta, and a neutral trend, the stock faces notable market swings without clear directional bias. The entertainment sector in China carries medium regulatory risk, and the company’s exposure to domestic currency adds a medium‑level currency risk. While analysts rate it a “strong buy,” the quantitative fundamentals suggest caution, and the upside potential is limited to about 13% based on current pricing.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • Current price near support with limited upside
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential revenue uplift from new series release
  • Strong cash position offsetting debt concerns
  • Neutral technical trend

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Undervalued relative to long‑term growth prospects if earnings recover
  • Low beta suggesting stability over longer horizons
  • Strategic partnerships with global platforms (Netflix, Disney, etc.)

Key Metrics & Analysis

Financial Health

Revenue Growth-52.20%
Profit Margin12.07%
P/E Ratio59.2
ROE3.95%
ROA1.12%
Debt/Equity17.90
P/B Ratio2.0
Op. Cash FlowCN¥709.0M
Free Cash FlowCN¥-639690304
Industry P/E17.9

Technical Analysis

TrendNeutral
RSI38.0
SupportCN¥7.68
ResistanceCN¥11.45
MA 20CN¥8.52
MA 50CN¥8.76
MA 200CN¥8.09
MACDBearish
VolumeDecreasing
Fear & Greed Index81.21

Valuation

Fair ValueCN¥4.92
Target PriceCN¥8.73
Upside/Downside13.57%
GradeOvervalued
TypeValue
Dividend Yield0.16%

Risk Assessment

Beta0.15
Volatility72.94%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.